Compare MNOV & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNOV | INVE |
|---|---|---|
| Founded | 2000 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7M | 80.1M |
| IPO Year | 2005 | 1997 |
| Metric | MNOV | INVE |
|---|---|---|
| Price | $1.27 | $3.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $7.00 | $5.50 |
| AVG Volume (30 Days) | ★ 79.4K | 37.6K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $257,917.00 | ★ $22,015,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.13 | $2.86 |
| 52 Week High | $2.20 | $4.07 |
| Indicator | MNOV | INVE |
|---|---|---|
| Relative Strength Index (RSI) | 32.65 | 45.52 |
| Support Level | $1.48 | $3.40 |
| Resistance Level | $1.51 | $3.70 |
| Average True Range (ATR) | 0.05 | 0.15 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 10.00 | 23.84 |
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.